<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biosimilars on FinanClub</title>
    <link>https://finan.club/tags/biosimilars/</link>
    <description>Recent content in Biosimilars on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 06 Aug 2023 10:13:12 +0000</lastBuildDate><atom:link href="https://finan.club/tags/biosimilars/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>1045 TEVA</title>
      <link>https://finan.club/us/teva/</link>
      <pubDate>Sun, 06 Aug 2023 10:13:12 +0000</pubDate>
      
      <guid>https://finan.club/us/teva/</guid>
      <description>score:1045
Chances: Teva Pharmaceutical Industries has agreed to pay up to $126 million to U.S. hospitals over 18 years to settle claims, which could resolve legal issues and potential liabilities. TEVA&amp;rsquo;s second-quarter results were strong, beating estimates for both earnings and sales, which may lead to increased investor confidence.</description>
    </item>
    
  </channel>
</rss>
